There is a lot of talk about all the BRD treatments that are available to cattle producers—and there are a number of antibiotics on the market. But Novartis Animal Health professional services veterinarian Dr. John Davidson says his best advice to producers is to focus on prevention, rather than treatment.
According to Dr. Mike Moore, professional services veterinarian with Novartis Animal Health, there are four factors critical to scours prevention: nutrition, environment, vaccination and colostrum. And, Moore says, the most important thing for producers to remember is that preventing scours is much more economical than treating sick calves.
When you visit the NCBA Trade Show in Tampa, make sure you stop by the Novartis Animal Health booth (#737) to find out how they can help increase your herd’s reproductive performance.
In this pre-convention interview with Brownfield, Novartis Animal Health’s director of veterinary services Dr. Doug Scholz talks about the important role that animal health plays in reproductive performance and discusses some new research that has potential implications for vaccinating pregnant cows.
Scholz also talks about their new pasteurella vaccine, NUPLURA PH.
According to Dr. Michael Moore, professional service veterinarian with Novartis Animal Health, the choice of vaccines for use in breeding females can have a significant impact on sustaining pregnancies.
In an interview with Brownfield at NAFB Trade Talk in Kansas City, Dr. Moore explained how Vira Shield HB provides protection against all the major reproductive and respiratory diseases with none of the risks or complications associated with modified-live vaccines.
Some areas of the country, especially southern portions, are seeing a higher-than-normal incidence of pinkeye in cattle this year.
Doug Scholz of Novartis Animal Health says heavy populations of face flies are a big part of the problem. The flies can irritate the eye and play a major role in transmitting the disease from animal to animal.
Scholz says while pinkeye may be a seasonal disease, it ranks high on the list of most expensive cattle health issues.
According to Novartis Animal Health professional services veterinarian Dr. Mark Hammer, swine dysentery has definitely reemerged and has become a growing problem for pork producers. Hammer says this contagious disease appears to have started in the eastern U.S., and veterinary reports indicate it has now spread to the Midwest. We visited with Dr. Hammer at the World Pork Expo trade show.
At the NCBA Trade Show in Nashville, we stopped by the Novartis Animal Health booth to find out more about their two new BRD vaccines.
Here’s how a Novartis news release describes NUPLURA PH:
NUPLURA™ PH is a new vaccine for beef and dairy cattle that provides fast-acting protection against bovine pneumonia caused by Mannheimia (Pasteurella) haemolytica.
M. haemolytica, formerly known as Pasteurella, is a highly transmissible bacteria and a leading cause of bovine respiratory disease (BRD) complex. Research has shown that M. haemolytica is present in nearly 75 percent of all diagnosed BRD cases, causing more death and economic loss than any other respiratory disease.
NUPLURA PH differs from other M. haemolytica vaccines because of the advanced cellular technology used to purify antigens in the vaccine. As the first and only U.S. cattle vaccine developed with recombinant technology, NUPLURA PH contains only purified leukotoxin to deliver the strongest immune response with minimal reactivity. It is the first new M. haemolytica vaccine available in the U.S. in over 10 years.
And here’s the scoop on the other new product, BRD Shield:
BRD Shield™ is a new modified-live vaccine (MLV) developed to protect non-pregnant beef and dairy cattle against bovine respiratory disease (BRD) complex.
BRD Shield provides broad-spectrum protection against leading viral diseases that contribute to BRD, including bovine virus diarrhea (BVD) Type 1 and Type 2, infectious bovine rhinotracheitis (IBR), parainfluenza 3 (PI3) and bovine respiratory syncytial virus (BRSV).
BRD Shield represents a significant advance in BVD protection, offering more complete coverage than other MLVs.
We discussed the two new products with Doug Scholz, director of veterinary services for Novartis Animal Health.
At the recent NAFB Trade Talk event in Kansas City we talked to Dr. Michael Moore, a professional services veterinarian with Novartis animal health, about increasing reproductive performance in beef and dairy herds through effective disease prevention programs.
Dr. Dennis Hermesch is a professional service veterinarian with Novartis Animal Health. He is trying to dispel the notion that killed vaccines only have application on the cow-calf side of the business. He says some recent research shows that there is a place for killed vaccines in the feedlot as well. Brownfield’s Ken Anderson talked with Dr. Hermesch at the Cattle Industry Convention and asked him why this information is important to feedlot operators.